Kither Biotech completes phase 1 trial of inhaled peptide therapy for respiratory diseases
Houdini Bio launches to solve therapeutic and commercial genetic medicine bottlenecks
Base to Base biotech podcast 64: Solving logistics challenges
Preclinical results for novel therapeutic candidate for rare neurodevelopmental disorders
Potential biomarker for targeted psoriasis therapy discovered
Base to Base biotech podcast 40: Anchored immunotherapy, and healing the skin
Sobi boosts gout battle with Arthrosi Therapeutics acquisition
Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis
InnoCare to move to phase 3 after achieving SLE endpoints
First precision therapy prostate cancer drug approved
FDA approves generalised myasthenia gravis drug
Breast cancer vaccine endpoints met with 74% immune response